Overview

Karolinska Institutet (English: Karolinska Institute) is one of Europe’s largest and most prominent medical universities. Founded in the early 19th century, it combines basic biomedical research, clinical training and specialised postgraduate education. The institute is recognised for its contributions to medicine and public health, extensive international collaborations and a high level of research activity.

Origins and development

Karolinska Institutet began in 1810 on the island of Kungsholmen in western Stockholm. Over time the institution expanded and relocated major functions to purpose-built facilities in Solna and later added a campus in Flemingsberg/Huddinge to serve southern Stockholm. Its growth parallels the development of modern clinical medicine in Sweden and the close integration of research and patient care.

Campuses and clinical partnerships

The institute operates across multiple campuses and works closely with the Karolinska University Hospital, which has major sites in Solna and Huddinge. Key features include:

  • Teaching hospitals and clinical wards that provide practical training for medical and health students.
  • Research centres focused on areas such as oncology, neuroscience, infectious disease and molecular medicine.
  • Interdisciplinary facilities that bring together clinicians, basic researchers and public health specialists.

Education, language and programmes

Karolinska Institutet offers undergraduate medical education, specialised master’s degrees and an extensive portfolio of PhD programmes. Many undergraduate medical courses are taught in Swedish, while most doctoral programmes and a growing number of international master’s courses are delivered in English. The institute trains a substantial share of Sweden’s future physicians and biomedical researchers.

Research reputation and rankings

The institute is a member of international research networks such as the League of European Research Universities and is frequently placed highly in subject-based rankings. Its strengths in clinical and pharmaceutical research have been highlighted in international assessments and subject rankings (see examples: global ranking overview, strong performance in medicine and pharmacy). Research at Karolinska spans basic laboratory science through to large clinical trials and population health studies.

Nobel Assembly and notable responsibilities

A distinctive role of Karolinska Institutet is that the Nobel Assembly based at the institute is responsible for selecting the Nobel Prize laureates in Physiology or Medicine. The Assembly is composed of faculty members and operates independently to evaluate nominations and research contributions (Nobel Prize in Physiology or Medicine). This responsibility highlights the institute’s international standing in biomedical research.

Distinguishing features

Karolinska Institutet is known for its close integration of research and clinical practice, a large international doctoral community, and active collaboration with hospitals and industry. Its combination of historic roots, modern facilities and a high concentration of biomedical expertise make it a central institution in Swedish and European medical science.